Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
Singapore: Glaxosmithkline declared that the phase III study of two anti-HER2 agents lapatinib and trastuzumab did not m...
Singapore: Focusing on the medical application of nanotechnology, Nanyang Technological University (NTU) in Singapore ...
Singapore: The National Institutes of Health (NIH), US, plans to invest an additional $100 million over the next three ...
Singapore: Almac said that Asian clinical trials must adopt highest GMP and GDP standards. Speaking to a news report, Mr...
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Excelra, headquartered in Hyderabad, India, has announced its collaboration with H M Pharma Consultancy (HMPC), a life s...
Singapore: Boehringer Ingelheim Biopharmaceuticals has installed a fast track process transfer to commercial scale. Comp...
Singapore: US Food and Drug Administration (FDA) has approved Merck's RAGWITEK Tablet indicated as immunotherapy for the...
Singapore: Australian drug development company Agenix has appointed international biomedical business development expert...
Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko...
Singapore: Genentech, a member of the Roche Group, has achieved primary endpoint of a significant improvement in HER2-po...
Singapore: Prostate cancer is becoming increasingly common due to globally growing numbers of elderly men, and scientist...
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...
Singapore: A former employee of the Japanese drug maker Novartis, was arrested with allegations of data manipulation. So...
Eisai's UK subsidiary, Eisai Europe, has received a positive opinion from the European Medicines Agency's Committee for ...
Singapore: Takeda Pharmaceutical and H. Lundbeck A/S have submitted a new drug application (NDA) to the US Food and Drug...
